Litcius/Paper detail

Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms

Ashok Kumar Jayavelu, Tina M. Schnöder, Florian Perner, Carolin Herzog, Arno Meiler, Gurumoorthy Krishnamoorthy, Nicolas Huber, Juliane Mohr, Bärbel Edelmann-Stephan, Rebecca Austin, Sabine Brandt, Francesca Palandri, Nicolas W.J. Schröder, Berend Isermann, Frank Edlich, Amit Sinha, Martin Ungelenk, Christian A. Hübner, Robert Zeiser, Susann Rahmig, Claudia Waskow, Iain Coldham, Thomas Ernst, Andreas Hochhaus, Stefanie Jilg, Philipp J. Jost, Ann Mullally, Lars Bullinger, Peter R. Mertens, Steven Lane, Matthias Mann, Florian H. Heidel

2020Nature156 citationsDOI

Topics & Concepts

Janus kinase 2HaematopoiesisJanus kinaseMAPK/ERK pathwayRNA splicingBiologyCancer researchKinaseSignal transductionCell biologySTAT3Stem cellGeneGeneticsRNAMyeloproliferative Neoplasms: Diagnosis and TreatmentRNA Research and SplicingCytokine Signaling Pathways and Interactions
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms | Litcius